Skip Navigation LinksHPV-Champion-Toolkit

aaa print

HPV Champion Toolkit


This toolkit has the best resources available to help you:

  • Educate other healthcare professionals 
  • Discuss HPV vaccination with parents
  • Make necessary changes in your practice to improve HPV vaccination rates. 

By focusing on ways you can make changes that will lead to improved HPV vaccination rates, YOU are an HPV champion. ​

SMK Accordion

Key point​s for improving HPV vaccination rates and saving lives:

(Click on the yellow arrow to expand the key points)
Don’t miss your chance to prevent cancer. Recommend the HPV vaccine for all boys and girls at age 11-12.

  • The vaccine is most effective at 11-12 —​​ it gives the highest level of protection at that age.
  • HPV associated cancers will affect 1 in 160 children.
  • Waiting is risky- an adolescent may not come back to your office again for several years, possibly after they are infected.
  • HPV infection can occur without intercourse.
Recommend the vaccine for all boys and girls at 11-12 years by saying, “Your child needs 3 vaccines today- Tdap, HPV and meningococcal,” or “Today, your child should have 3 vaccines. They’re designed to protect him from meningitis, cancers caused by HPV and tetanus, diphtheria, & pertussis.”

  • Recommend the HPV vaccine in​ the same way at the same time as Tdap and meningococcal. Bundling is more effective.
  • Interviews show that most parents want this vaccine for their children.
  • Your recommendation matters most to parents.
  • Recommend HPV vaccine at every opportunity, including well and sick visits.
  • Parents ask questions to get your reassurance that they are making the right decision. Simple answers about cancer prevention and personal attestations work best.
Guarantee protection. Make sure your practice has a system in place to bring back patients to complete the series.

  • Tell pa​​​rents that this is a 3-dose series.
  • Schedule the patient or give them a reminder before leaving the office.
  • Recall patients using​ your electronic medical record, immunization registry, postcards, or phone/text messages. Ask parents how they want to be reminded. Local health departments or registries may be able to help.
  • Standing orders are effective and efficient.
9vHPV: What are the new recommendations?

  • 9vHPV, 4vHPV or 2vHPV can be used for routine vaccination of females aged 11 or 12 years and females through age 26 years who have not been vaccinated previously or who have not completed the 3-dose series.
  • 9vHPV or 4vHPV can be used for routine vaccination of males aged 11 or 12 years and males through age 26 years who have not been vaccinated previously or who have not completed the 3-dose series.
  • ​ACIP and AAP recommends either 9vHPV or 4vHPV vaccination for men who have sex with men and immunocompromised persons (including those with HIV infection) through age 26 years if not vaccinated previously.

Toolkit Resources:

(Click on the yellow arrow to expand the resources)
Making a Change in Your Office
Tip: For CME and MOC activities, see CME/MOC section below.
What's New with HPV Vaccine

Tip: Check back often for the latest information regarding HPV vaccine!

  • FDA statements for Gardasil, Cervarix and Gardasil 9 
    • Vaccine Information Statements (VISs) are information sheets produced by the Centers for Disease Control and Prevention (CDC). VISs explain both the benefits and risks of a vaccine to adult vaccine recipients and the parents or legal representatives of vaccinees who are children and adolescents. Federal law requires that VISs be handed out whenever certain vaccinations are given (before each dose).
  • ACIP recommendations for 9vHPV 
    • The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States.  
  • MMWR: Use of 9-Valent Human Papillomavirus (HPV) Vaccine
    • Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
  • 9-valent HPV Vaccine FAQs
Grand Rounds / Resident Teaching Sessions

Tip:  Knowing your rates is the first step to improving them.  If you want to include data in your presentation, you can access state teen vaccination data, we suggest using the 2014 NIS-Teen Vaccination Coverage Data Tables.

  • For assistance identifying a speaker for a grand rounds session, contact: 
  • Preparing your own presentation The following slide sets are available for your use, and can be modified to fit your audience and geographic data. (For a modifiable version in Power Point format, please email  
    • You Are The Key to HPV Cancer Prevention:  60 Minute Presentation (Clinician Focus) 
    • You Are The Key to HPV Cancer Prevention:  20 Minute Presentation (Non Clinician Focus) 
    • How to Increase Adolescent Immunization Rates 

CME / MOC Activities for Clinicians
Tip:  The following online learning opportunities are focused on improving HPV vaccination rates.   

PediaLink Courses (Free)
  • Adolescent Immunizations: Strongly Recommending the HPV Vaccine 
    • Credit Information
      • AMA PRA Category 1 Credit(s)™: 1.00
      • AAP Credit: 1.00
      • NAPNAP Credit: 1.00
      • Pharmacology Rx: 0.00
    • This course discusses strategies for strongly recommending the HPV vaccine and will offer information to help pediatricians address their patients’ concerns about the vaccine  
  • Adolescent Immunizations: Office Strategies
    • Credit Information
      • AMA PRA Category 1 Credit(s)™: 1.00
      • AAP Credit: 1.00
      • NAPNAP Credit: 1.00
      • Pharmacology Rx: 0.00
    • This course provides strategies for offices to optimize their adolescent immunization efforts and improve their adolescent immunization rates. 
EQIPP Course (CME & MOC Part 4) (AAP Member: Free, Non-Member: $199) 
  • EQIPP: Immunizations – Improve Your Practice Rates 
    • Credit Information: 
      • AMA PRA Category 1 Credit(s)™: 28.00
      • AAP Credit: 28.00
      • MOC Part 4: 25.00
      • NAPNAP Credit: 28.00
      • Performance Improvement: 20.00
      • Pharmacology Rx: 4.25
    • Increasing immunization rates for any practice can be challenging.  This EQIPP course is designed to identify immunization rates in your practice, barriers to immunization delivery systems and techniques to overcome those barriers through the use of clear aims that reflect expert principles and proven quality improvement methods and tools. 
MedScape Course (Free):
Postgraduate Institute for Medicine and National AHEC Organization (FREE):
  • You are the Key to HPV Cancer Prevention Continuing Education Training Self-Study Guide 
    • Credit Information:
      • Physicians – maximum of 1.5 AMA PRA Category 1 Credits™
      • Pharmacists – 1.4 contact hours (0.14 CEUs) (Universal Activity Number - 0809-9999-15-289-H01-P)
      • Nurses – 1.4 contact hours All other healthcare professionals completing this course will be issued a statement of participation.
    • This activity has been designed to meet the educational needs of health professionals who provide and/or promote immunizations including physicians, registered nurses, and pharmacists.
Video Clips
TipWe recommend making sure that you will have internet access at the presentation location, or downloading the video and saving it to your computer or flash drive. (Note: Videos that are accessed through YouTube can not be downloaded to a computer or flash drive. If you are showing a YouTube video, you will need to have internet access.)
Printable Resources

Tip: These can also be shared electronically and/or posted to organization websites for further distribution.  

Public Communication

Tip:  We recommend using one hashtag for all of your HPV vaccination tweets and posts to unify your social media messages.

Success Stories

Click here to read the success stories

The National HPV Vaccination Roundtable

The National HPV Vaccination Roundtable is a coalition of public, private, and voluntary organizations with expertise relevant to increasing HPV vaccination coverage in the United States as a way to reduce illness and death from HPV-associated cancers, through coordinated leadership, strategic planning, and advocacy. 

Members are organizations that designate one representative to serve on the Roundtable. Based on meeting space limitations and budget, 65-70 organizations were invited to participate, and more groups will be included moving forward. Most of the organizations are national, but some are statewide. An 11-member Steering Committee was selected based on their organizations’ involvement in HPV vaccination activities or prevention of HPV-associated cancers, their ability to deliver education or vaccination, or their expertise relevant to expanding HPV vaccination. 

This publication was supported by the Cooperative Agreement Number, 1H23IP000952, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.